• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

36.78 +0.45 (+1.25%)
Streaming Delayed Price Updated: 1:48 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,621,880
Open 36.29
Bid (Size) 36.78 (500)
Ask (Size) 36.79 (700)
Prev. Close 36.33
Today's Range 36.13 - 37.44
52wk Range 35.85 - 81.44
Shares Outstanding N/A
Dividend Yield 3.18%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
Today 10:27 EDT
The biotechnology landscape witnessed a defining moment on March 26, 2026, as Wave Life Sciences (Nasdaq: WVE) released highly anticipated interim Phase 1 data from its INLIGHT trial. The study, which... 
Via MarketMinute
News headline image
Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment
Today 10:25 EDT
On March 26, 2026, Kodiak Sciences (Nasdaq: KOD) saw its shares ignite, surging 19% in heavy trading following the announcement of overwhelmingly positive topline results from its Phase 3 GLOW2 study.... 
Via MarketMinute

Performance

YTD
-29.8%
-29.8%
1 Month
-7.2%
-7.2%
3 Month
-30.0%
-30.0%
6 Month
-37.4%
-37.4%
1 Year
-50.0%
-50.0%

More News

Read More
News headline image
Surging Oil Prices Spark Market Jitters ↗
March 25, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer ↗
March 24, 2026
Via The Motley Fool
News headline image
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
March 23, 2026
Via MarketMinute
Topics ETFs Earnings
News headline image
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? ↗
March 22, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Buy Eli Lilly Stock Before April 10? ↗
March 22, 2026
Via The Motley Fool
News headline image
Is This Stock a Buy on the Dip? ↗
March 21, 2026
Via The Motley Fool
News headline image
This Hims & Hers Move Could Destroy Competitors ↗
March 21, 2026
Via The Motley Fool
News headline image
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up? ↗
March 20, 2026
Via The Motley Fool
News headline image
Is It Too Late to Buy Eli Lilly? ↗
March 19, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Reason I'm Never Selling Novo Nordisk Stock ↗
March 19, 2026
Via The Motley Fool
News headline image
Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot
March 18, 2026
Via Finterra
Topics Intellectual Property
News headline image
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk ↗
March 18, 2026
Via Stocktwits
News headline image
The Best Healthcare Stocks to Buy With $50 Right Now ↗
March 18, 2026
Via The Motley Fool
News headline image
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗
March 17, 2026
Via The Motley Fool
News headline image
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move ↗
March 17, 2026
Via The Motley Fool
Topics Stocks
News headline image
LLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff ↗
March 17, 2026
Via Stocktwits
News headline image
Why Eli Lilly Stock Just Dropped ↗
March 17, 2026
Via The Motley Fool
News headline image
This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock ↗
March 17, 2026
Via The Motley Fool
News headline image
Should You Avoid Pfizer? Here's the Key Risk to Watch ↗
March 17, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks ↗
March 16, 2026
Via The Motley Fool
News headline image
Eli Lilly’s Employer Push Could Unlock New GLP-1 Demand ↗
March 15, 2026
Via MarketBeat
MarketBeat Week in Review – 03/09 - 03/13 ↗
March 14, 2026
Via MarketBeat

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 36.78
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 03/26/26 01:48 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap